Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Closing in on cancer | Merus
Merus Expands Colorectal Cancer Focus with Promising Petosemtamab Data ...
Merus grabs first-in-class US approval for NRG1 cancer drug | pharmaphorum
Genmab to buy Dutch cancer drugmaker Merus for $8 billion | Reuters
Merus makes push into colorectal cancer with early positive data
Merus Shares Surge Amid Promising Cancer Trial Updates
Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer ...
Merus Cancer Drug Shows 63% Response Rate in Trial, Reports Q2 Earnings ...
Denmark's Genmab buys Dutch cancer drugmaker Merus for $8 bn ...
Merus Shares Surge with Impressive Interim Cancer Trial Data
Merus Will Have a Best-in-Class Treatment for Head and Neck Cancer ...
Merus touts cancer drug's strong profile with new data drop
Merus stock gains on cancer drug data (MRUS:NASDAQ) | Seeking Alpha
Genmab Acquires Dutch Cancer Drugmaker Merus for $8 Billion
Genmab to Acquire Merus for $8 Billion, Expanding Cancer Drug Pipeline ...
Merus drug and Keytruda shrank tumors in patients with head and neck cancer
ASCO 2024: Merus touts positive Phase II data for head and neck cancer ...
Genmab agrees $8bn takeover of cancer biotech Merus | pharmaphorum
Early Merus drug data show survival boost in head and neck cancer | STAT
Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough
Merus partners with oncology institute on cancer treatments - Clinical ...
Genmab Acquires Merus for $8 Billion, Expands Cancer Pipeline | Aspen ...
Genmab to buy Dutch cancer drugmaker Merus for $8 billion, ETPharma
Genmab Acquires Merus for $8B, Boosts Cancer Care | Faisal Zubair ...
Merus cancer bispecific lives up to investors' expectations
Genmab to acquire closely watched cancer drug in $8B Merus buyout ...
Merus wins in head-to-head with Bicara for head and neck cancer
Genmab Buys Rising Cancer Star Merus for $8B - BioSpace
More on the Rise of Colorectal Cancer in 20s and 30s - Merus Gastro
Colon Cancer Screening Suwanee GA | Merus Gastroenterology
Merus Faces Setback Following Interim Report for Lung Cancer Therapy ...
Al. Neyer is now Merus
04 December 2024: Merus gains accelerated approval for first-in-class ...
Merus to Present at Upcoming Investor Conferences
Merus updates on Petosemtamab+Pembrolizumab data in HNSCC
Merus N.V. (MRUS): A Bull Case Theory
Merus Announces the Journal Publication of Petosemtamab Mechanism of Action
It’s #WorldCancerDay and our focus is on patients living with cancer ...
Merus Buyout Rumor Gets Retail Traders Buzzing — Genmab Said To Be ...
Merus surges after Genmab says it will acquire it for $8 billion ...
Genmab to buy Dutch biotech firm Merus for €6.8 billion - DutchNews.nl
Genmab To Acquire Merus In $8 Bln Cash Deal
Sun-Mercury alignment brings clarity and connection for Cancer
Cancer horoscope warns of overspending risks amid social plans
Partner's Bizengri is first drug for rare, aggressive cancer | pharmaphorum
Michigan Basketball Freshman Dealing With Cancer - Yahoo Sports
This Week in Science: Giant Octopuses, a Promising Cancer Vaccine, And ...
Doctor explains why cancer symptoms only appear '10 to 15 years' after ...
Vilniaus rajono socialdemokratai pristatė tris kandidatus į merus ...
Venus in Cancer allows us to feel seen and heard
Man diagnosed with cancer months after doctors dismissed symptoms and ...
A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved ...
Australia health news: Treatment for deadly blood cancer multiple ...
Routine scans may reveal tumour aggressiveness in head and neck cancer ...
Funding the Next Generation of Cancer Therapies
Merus advances the world's first LGR5-targeted bispecific antibody into ...
Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1 ...
Merus Presents First in Human Data on MCLA-129 at the 34th EORTC/NCI ...
Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer ...
Merus N.V. on LinkedIn: #closeinoncancer #cancerresearchsaveslives
#closeinoncancer | Merus N.V.
Merus Collaborates with Partner Therapeutics to Commercialize ...
Merus Stock Catapults To Record High After Beating Expectations In ...
Rays of Resilience: Navigating Hope Amidst Meru’s Cancer Puzzle - Radio ...
Merus's Preclinical Bispecific Zeno Demonstrates Efficacy in Cancer Models
Merus | Fierce Biotech
Merus, Caris Life Sciences Collaborate to Detect NRG1 Fusions in Cancer ...
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in ...
Merus announces First Patient Dosed in Phase 2 Trial of
Homepage - Merus Gastroenterology & Gut Health | John's Creek, GA
#closeinoncancer #hnscc | Merus N.V.
Merus links up with Partner Therapeutics on zenocutuzumab | The ...
Moody Aldrich Partners LLC Reduces Position in Merus N.V. $MRUS
#hnscc #closeinoncancer | Merus N.V.
Genmab's $8B Acquisition of Merus: A New Era in Head & Neck Cancer ...
Foundation Medicine and Merus Partner to Develop Companion Diagnostic ...
Merus N.V. on LinkedIn: #hnscc #closeinoncancer
Merus N.V. - 2025 ASCO® Annual Meeting
Exciting development for head and neck cancer patients and a proud ...
Merus N.V. on LinkedIn: Merus
US drug body approves Merus' therapy for lung, pancreatic cancer ...
Gilead, Merus Strike Deal to Develop Novel Trispecific T-Cell ...
The Importance of Colonoscopy Screening: Detecting Colon Cancer Early ...
Merus N.V. - ASCO Annual 2024
Pipeline | Merus N.V.
About Us | Merus
Merus, Bicara Present Promising HNSCC Trial Data at ASCO 2025, Advance ...
Merus’ Zeno Interim Data Continues to Demonstrate Robust and Durable ...
Merus’ Petosemtamab Interim Data Demonstrates Clinically Meaningful ...
荷蘭癌癥免疫療法公司：Merus B.V.(MRUS) – 美股投資指南
Merus’ Zenocutuzumab, a HER2-HER3 Bispecific Antibody, Successfully ...
Merus: Riding The Bispecific Wave In Oncology (NASDAQ:MRUS) | Seeking Alpha
Slide 20
Merus’ Bispecific Shows ‘Best in Disease’ Profile in Head-and-Neck ...
MRUS Stock Forecast, Price & News (Merus) - MarketBeat
Merus' Bizengri wins FDA nod as 1st drug to target NRG1+ cancers
Merus: Important Catalysts In 2018 (NASDAQ:MRUS) | Seeking Alpha
AACR Annual Meeting Coverage | AACR Conference Coverage | AACR 2025
がん治療革新への一歩、GileadとMerusが抗体薬開発で提携 - イノベトピア
Preventing Colorectal Cancer: The Vital Role of Colonoscopy Screening ...
